Selected research
Market Structure
Global Parenteral Nutrition Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Parenteral Nutrition Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Parenteral Nutrition Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Parenteral Nutrition Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Parenteral Nutrition Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Parenteral Nutrition Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Parenteral Nutrition Products include Teva Pharmaceutical, Sichuan Kelun Pharmaceutical, Pfizer, B. Braun Melsungen, Baxter International, Otsuka Pharmaceutical, Grifols International and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Parenteral Nutrition Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Parenteral Nutrition Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Parenteral Nutrition Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parenteral Nutrition Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Parenteral Nutrition Products Segment by Company
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Pfizer
B. Braun Melsungen
Baxter International
Otsuka Pharmaceutical
Grifols International
Fresenius Kabi
Parenteral Nutrition Products Segment by Type
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Carbohydrates
Trace Elements
Vitamins and Minerals
Parenteral Nutrition Products Segment by Application
Premature Infants, Neonates and Children
Chronic Disease Patients
Geriatrics
Parenteral Nutrition Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Parenteral Nutrition Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parenteral Nutrition Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parenteral Nutrition Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Parenteral Nutrition Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solution
- Carbohydrates
- Trace Elements
- Vitamins and Minerals
Applications
- Premature Infants, Neonates and Children
- Chronic Disease Patients
- Geriatrics
Companies covered
- Teva Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Pfizer
- B. Braun Melsungen
- Baxter International
- Otsuka Pharmaceutical
- Grifols International
- Fresenius Kabi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Parenteral Nutrition Products Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Parenteral Nutrition Products Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Parenteral Nutrition Products Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Parenteral Nutrition Products Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Parenteral Nutrition Products Market Dynamics
- 2.1 Parenteral Nutrition Products Industry Trends
- 2.2 Parenteral Nutrition Products Industry Drivers
- 2.3 Parenteral Nutrition Products Industry Opportunities and Challenges
- 2.4 Parenteral Nutrition Products Industry Restraints
3 Parenteral Nutrition Products Market by Manufacturers
- 3.1 Global Parenteral Nutrition Products Revenue by Manufacturers (2021-2026)
- 3.2 Global Parenteral Nutrition Products Sales by Manufacturers (2021-2026)
- 3.3 Global Parenteral Nutrition Products Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Parenteral Nutrition Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Parenteral Nutrition Products Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Parenteral Nutrition Products Manufacturers, Product Type & Application
- 3.7 Global Parenteral Nutrition Products Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Parenteral Nutrition Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Parenteral Nutrition Products Players Market Share by Revenue in 2025
- 3.8.3 2025 Parenteral Nutrition Products Tier 1, Tier 2, and Tier 3
4 Parenteral Nutrition Products Market by Type
- 4.1 Parenteral Nutrition Products Type Introduction
- 4.1.1 Parenteral Lipid Emulsion
- 4.1.2 Single Dose Amino Acid Solution
- 4.1.3 Carbohydrates
- 4.1.4 Trace Elements
- 4.1.5 Vitamins and Minerals
- 4.2 Global Parenteral Nutrition Products Sales by Type
- 4.2.1 Global Parenteral Nutrition Products Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Parenteral Nutrition Products Sales by Type (2021-2032)
- 4.2.3 Global Parenteral Nutrition Products Sales Market Share by Type (2021-2032)
- 4.3 Global Parenteral Nutrition Products Revenue by Type
- 4.3.1 Global Parenteral Nutrition Products Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Parenteral Nutrition Products Revenue by Type (2021-2032)
- 4.3.3 Global Parenteral Nutrition Products Revenue Market Share by Type (2021-2032)
5 Parenteral Nutrition Products Market by Application
- 5.1 Parenteral Nutrition Products Application Introduction
- 5.1.1 Premature Infants, Neonates and Children
- 5.1.2 Chronic Disease Patients
- 5.1.3 Geriatrics
- 5.2 Global Parenteral Nutrition Products Sales by Application
- 5.2.1 Global Parenteral Nutrition Products Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Parenteral Nutrition Products Sales by Application (2021-2032)
- 5.2.3 Global Parenteral Nutrition Products Sales Market Share by Application (2021-2032)
- 5.3 Global Parenteral Nutrition Products Revenue by Application
- 5.3.1 Global Parenteral Nutrition Products Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Parenteral Nutrition Products Revenue by Application (2021-2032)
- 5.3.3 Global Parenteral Nutrition Products Revenue Market Share by Application (2021-2032)
6 Global Parenteral Nutrition Products Sales by Region
- 6.1 Global Parenteral Nutrition Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Parenteral Nutrition Products Sales by Region (2021-2032)
- 6.2.1 Global Parenteral Nutrition Products Sales by Region (2021-2026)
- 6.2.2 Global Parenteral Nutrition Products Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Parenteral Nutrition Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Parenteral Nutrition Products Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Parenteral Nutrition Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Parenteral Nutrition Products Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Parenteral Nutrition Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Parenteral Nutrition Products Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Parenteral Nutrition Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Parenteral Nutrition Products Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Parenteral Nutrition Products Revenue by Region
- 7.1 Global Parenteral Nutrition Products Revenue by Region
- 7.1.1 Global Parenteral Nutrition Products Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Parenteral Nutrition Products Revenue by Region (2021-2026)
- 7.1.3 Global Parenteral Nutrition Products Revenue by Region (2027-2032)
- 7.1.4 Global Parenteral Nutrition Products Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Parenteral Nutrition Products Revenue (2021-2032)
- 7.2.2 North America Parenteral Nutrition Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Parenteral Nutrition Products Revenue (2021-2032)
- 7.3.2 Europe Parenteral Nutrition Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Parenteral Nutrition Products Revenue (2021-2032)
- 7.4.2 Asia-Pacific Parenteral Nutrition Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Parenteral Nutrition Products Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Parenteral Nutrition Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceutical
- 8.1.1 Teva Pharmaceutical Company Information
- 8.1.2 Teva Pharmaceutical Business Overview
- 8.1.3 Teva Pharmaceutical Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceutical Parenteral Nutrition Products Product Portfolio
- 8.1.5 Teva Pharmaceutical Recent Developments
- 8.2 Sichuan Kelun Pharmaceutical
- 8.2.1 Sichuan Kelun Pharmaceutical Company Information
- 8.2.2 Sichuan Kelun Pharmaceutical Business Overview
- 8.2.3 Sichuan Kelun Pharmaceutical Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sichuan Kelun Pharmaceutical Parenteral Nutrition Products Product Portfolio
- 8.2.5 Sichuan Kelun Pharmaceutical Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Parenteral Nutrition Products Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 B. Braun Melsungen
- 8.4.1 B. Braun Melsungen Company Information
- 8.4.2 B. Braun Melsungen Business Overview
- 8.4.3 B. Braun Melsungen Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 B. Braun Melsungen Parenteral Nutrition Products Product Portfolio
- 8.4.5 B. Braun Melsungen Recent Developments
- 8.5 Baxter International
- 8.5.1 Baxter International Company Information
- 8.5.2 Baxter International Business Overview
- 8.5.3 Baxter International Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Baxter International Parenteral Nutrition Products Product Portfolio
- 8.5.5 Baxter International Recent Developments
- 8.6 Otsuka Pharmaceutical
- 8.6.1 Otsuka Pharmaceutical Company Information
- 8.6.2 Otsuka Pharmaceutical Business Overview
- 8.6.3 Otsuka Pharmaceutical Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Otsuka Pharmaceutical Parenteral Nutrition Products Product Portfolio
- 8.6.5 Otsuka Pharmaceutical Recent Developments
- 8.7 Grifols International
- 8.7.1 Grifols International Company Information
- 8.7.2 Grifols International Business Overview
- 8.7.3 Grifols International Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Grifols International Parenteral Nutrition Products Product Portfolio
- 8.7.5 Grifols International Recent Developments
- 8.8 Fresenius Kabi
- 8.8.1 Fresenius Kabi Company Information
- 8.8.2 Fresenius Kabi Business Overview
- 8.8.3 Fresenius Kabi Parenteral Nutrition Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Fresenius Kabi Parenteral Nutrition Products Product Portfolio
- 8.8.5 Fresenius Kabi Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Parenteral Nutrition Products Value Chain Analysis
- 9.1.1 Parenteral Nutrition Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Parenteral Nutrition Products Production Mode & Process
- 9.2 Parenteral Nutrition Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Parenteral Nutrition Products Distributors
- 9.2.3 Parenteral Nutrition Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst